<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03013270</url>
  </required_header>
  <id_info>
    <org_study_id>ARISTOS-HF</org_study_id>
    <nct_id>NCT03013270</nct_id>
  </id_info>
  <brief_title>Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure</brief_title>
  <acronym>ARISTOS-HF</acronym>
  <official_title>Aerobic, Resistance, Inspiratory Training Outcomes in Heart Failure. The ARISTOS-HF Trial: a Prospective Randomized Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onassis Cardiac Surgery Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Asklepieion Voulas General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Onassis Cardiac Surgery Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effects of aerobic, resistance, inspiratory training modalities
      outcomes in functional capacity and quality of life of heart failure (HF) patients, aiming
      for the 'optimum' (greek, αριστος=aristos) training program for HF patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure is a clinical syndrome characterized by symptoms of dyspnea, exercise
      intolerance and decreased quality of life. A weakness in both inspiratory and peripheral
      muscles is also reported. Aerobic training (AT) improves the functional status of HF patients
      (level of evidence IA). Additional benefits of inspiratory muscle training (IMT) and/or
      resistance training (RT) when combined with aerobic training (AT) in HF symptoms have also
      been found.

      Four exercise groups will be studied in order to identify the optimum exercise program I.
      Aerobic-Resistance-Inspiratory training (ARIS) group II. Aerobic-Resistance training (ARS)
      group III. Aerobic-Inspiratory training (AIS) group IV. Aerobic Training (AT) group
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in peak oxygen consumption (peakVO2, in ml/kg/min) using cardiopulmonary exercise testing (Medgraphics CPX/MAX, Medical Graphics Corp., St. Paul, MN, USA)</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>walking distance using the 6-minute walking test (6MWT)</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life using the Minnesota Living with Heart Failure questionnaire</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>echocardiography (Ultrasound Vivid 7, General Electric Healthcare, Fairfield, CT, USA) with the biplane Simpson' s method</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular end-diastolic diameter (LVEDD in mm) using resting 2-dimensional echocardiography (Ultrasound Vivid 7, General Electric Healthcare, Fairfield, CT, USA) with the Teichholz method</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular end-systolic diameter (LVESD in mm) using resting 2-dimensional echocardiography (Ultrasound Vivid 7, General Electric Healthcare, Fairfield, CT, USA) with the Teichholz method</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in dyspnoea using the Borg scale (0-10) at the end of exercise testing</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in maximal inspiratory pressure (PImax in cmH2O) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in inspiratory work capacity (sustained maximal inspiratory pressure (SPImax in cmH2O/s) using an electronic pressure manometer with computer software (TRAINAIR®, Project Electronics Ltd, London, UK).</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in skeletal muscle strength will be evaluated using the quadriceps 1 repetition maximum (1RM)</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in skeletal muscle endurance will be evaluated using the quadriceps muscle endurance with the product: 50%1Repetition Maximum x number of reps</measure>
    <time_frame>Before and after 12 weeks</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>ARIS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic-Resistance-Inspiratory</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ARS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aerobic-Resistance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AIS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aerobic-Inspiratory</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AT group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aerobic Training</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic-Resistance-Inspiratory</intervention_name>
    <description>Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1 Repetition Maximum (1RM) for quads training and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets) for 10 min, combined also with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 20 min (Aerobic (30min) + Resistance (10min) + Inspiratory (20min) = 60 min)</description>
    <arm_group_label>ARIS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic-Resistance</intervention_name>
    <description>Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with resistance training at an intensity of 50% of 1RM for quads training, pectoralis m, serratus anterior m, and latissimus dorsi m and upper limb exercises (elbow flex/shoulder flex/abd) using dumbbells (1-2 kg) (12-15 reps/3sets).
(Aerobic (30min) + Resistance (30min) = 60 min)</description>
    <arm_group_label>ARS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic-Inspiratory</intervention_name>
    <description>Patients will be submitted to a 12 week, 3 times/week, continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with inspiratory muscle training with a flow-resistive loading system at an intensity of 60% of maximal inspiratory pressure/sustained maximal inspiratory pressure (PImax/SPImax) for 30min (Aerobic (30min) + Inspiratory (30min) = 60 min)</description>
    <arm_group_label>AIS group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Training</intervention_name>
    <description>Patients will be submitted to a 12 week, 3 times/week continuous aerobic (e.g. bike) training programme at an intensity of 60-80% max HR (or peakVO2) for 30 min combined with callisthenics or treadmill (at the same intensity) for 30 min (Aerobic training = 60 min)</description>
    <arm_group_label>AT group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic heart failure (from New York Heart Association (NYHA) functional class II to
             NYHA III)

          -  Left ventricular ejection fraction below or equal to 35%

        Exclusion Criteria:

          -  Uncontrolled arrhythmia

          -  Pulmonary oedema or pulmonary congestion in the last 30 days

          -  Cognitive, neurological or orthopaedic limitations

          -  Respiratory infection during 30 days before the start of the study

          -  Pulmonary limitations (e.g COPD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stamatis Adamopoulos, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Onassis Cardiac Surgery Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ioannis Laoutaris, PhD</last_name>
    <phone>210 9493000</phone>
    <phone_ext>1188</phone_ext>
    <email>ylaoutaris@yahoo.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Athanasios Dritsas, MD</last_name>
    <phone>210 9493000</phone>
    <phone_ext>1163</phone_ext>
    <email>thanosdr@otenet.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Onassis Cardiac Surgery Center</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>176 74</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioannis Laoutaris, PhD</last_name>
      <phone>210 9493000</phone>
      <phone_ext>1811</phone_ext>
      <email>ylaoutaris@yahoo.gr</email>
    </contact>
    <contact_backup>
      <last_name>Athanasios Dritsas, MD</last_name>
      <phone>210 9493000</phone>
      <phone_ext>1163</phone_ext>
      <email>thanosdr@otenet.gr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Asklepieion Voulas General Hospital</name>
      <address>
        <city>Voula</city>
        <state>Attica</state>
        <zip>16673</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Athanasios Manolis, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Manolis Kallistratos, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Niki Dimaki, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Andriopoulou, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Laoutaris ID, Adamopoulos S, Manginas A, Panagiotakos DB, Kallistratos MS, Doulaptsis C, Kouloubinis A, Voudris V, Pavlides G, Cokkinos DV, Dritsas A. Benefits of combined aerobic/resistance/inspiratory training in patients with chronic heart failure. A complete exercise model? A prospective randomised study. Int J Cardiol. 2013 Sep 1;167(5):1967-72. doi: 10.1016/j.ijcard.2012.05.019. Epub 2012 May 31.</citation>
    <PMID>22658571</PMID>
  </reference>
  <reference>
    <citation>Adamopoulos S, Schmid JP, Dendale P, Poerschke D, Hansen D, Dritsas A, Kouloubinis A, Alders T, Gkouziouta A, Reyckers I, Vartela V, Plessas N, Doulaptsis C, Saner H, Laoutaris ID. Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: The Vent-HeFT trial: a European prospective multicentre randomized trial. Eur J Heart Fail. 2014 May;16(5):574-82. doi: 10.1002/ejhf.70. Epub 2014 Mar 14.</citation>
    <PMID>24634346</PMID>
  </reference>
  <reference>
    <citation>Beckers PJ, Denollet J, Possemiers NM, Wuyts FL, Vrints CJ, Conraads VM. Combined endurance-resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. Eur Heart J. 2008 Aug;29(15):1858-66. doi: 10.1093/eurheartj/ehn222. Epub 2008 May 30.</citation>
    <PMID>18515805</PMID>
  </reference>
  <reference>
    <citation>Smart NA. How do cardiorespiratory fitness improvements vary with physical training modality in heart failure patients? A quantitative guide. Exp Clin Cardiol. 2013 Winter;18(1):e21-5.</citation>
    <PMID>24294043</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>April 15, 2018</last_update_submitted>
  <last_update_submitted_qc>April 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Onassis Cardiac Surgery Centre</investigator_affiliation>
    <investigator_full_name>Laoutaris Ioannis</investigator_full_name>
    <investigator_title>PhD FESC</investigator_title>
  </responsible_party>
  <keyword>Rehabilitation</keyword>
  <keyword>Exercise</keyword>
  <keyword>Training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

